Perrigo Company plc PRGO

NYS: PRGO | ISIN: IE00BGH1M568 22/04/2024

30,06 USD (-2,40%)

(-2,40%) 22/04/2024

Grafiek Perrigo Company plc

Grafiek Perrigo Company plc

1 dag1d -2,40%
1 week1w 0,33%
1 maand1m -3,06%
3 maanden3m -9,59%
6 maanden6m 3,33%
1 jaar1j -16,71%
5 jaar5j -39,35%

Perrigo Company plc in het nieuws

Toon enkel gratis nieuws

9 april 2024 · Opill and WNBA Team Up for Groundbreaking Partnership · Persbericht

4 maart 2024 · Perrigo Commences Shipments of Opill® to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United States · Persbericht

29 februari 2024 · Perrigo to Attend UBS Global Consumer and Retail Conference · Persbericht

27 februari 2024 · Perrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency Program · Persbericht

26 februari 2024 · Perrigo Increases its Quarterly Dividend · Persbericht

13 februari 2024 · Perrigo to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 27, 2024 · Persbericht

10 november 2023 · Perrigo Announces Cash Tender Offer for Notes · Persbericht

7 november 2023 · Perrigo Reports Third Quarter Fiscal Year 2023 Financial Results From Continuing Operations · Persbericht

2 november 2023 · Perrigo Announces Quarterly Dividend · Persbericht

31 oktober 2023 · Perrigo to Attend Upcoming Consumer Investor Conferences · Persbericht

Profiel Perrigo Company plc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

CEO: Murray Kessler

Werknemers: 5.210

Aandelen Perrigo Company plc

Beurswaarde: 4,17 miljard USD

Effecten: 135,52 miljoen

Winst per aandeel (12 maand): PLUS

Beta: 0,68

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe